PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Cenobamate - Epilepsy

PAD Profile : Cenobamate - Epilepsy

Keywords :
Focal onset seizures
Brand Names Include :
Ontozry

Traffic Light Status

Status 1 of 1.

Status :
Red
Important
Formulations :
  • Tablets
Important Information :
For initiation by tertiary centres only
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
02 March 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee recommends the use of cenobamate in the treatments of focal onset seizures in epilepsy, in line with NICE guidance  (TA753).

A RED traffic light status will be applied to cenobamate for this indication.

Associated BNF Codes

04. Central Nervous System
04.08.01. Control of epilepsy
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More